(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-07-10 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 618690
Date | Daily Closing Price | Open | High | Low | Volume |
10 Thu Jul 2025 | 0.27 | 0.28 | 0.29 | 0.26 | 0.841 times |
09 Wed Jul 2025 | 0.28 | 0.26 | 0.28 | 0.26 | 1.467 times |
08 Tue Jul 2025 | 0.25 | 0.25 | 0.26 | 0.24 | 0.548 times |
07 Mon Jul 2025 | 0.24 | 0.25 | 0.25 | 0.24 | 0.53 times |
03 Thu Jul 2025 | 0.25 | 0.25 | 0.25 | 0.24 | 0.743 times |
02 Wed Jul 2025 | 0.24 | 0.24 | 0.24 | 0.23 | 0.652 times |
01 Tue Jul 2025 | 0.23 | 0.24 | 0.25 | 0.23 | 0.804 times |
30 Mon Jun 2025 | 0.24 | 0.24 | 0.25 | 0.24 | 0.906 times |
27 Fri Jun 2025 | 0.25 | 0.24 | 0.25 | 0.23 | 1.515 times |
26 Thu Jun 2025 | 0.24 | 0.24 | 0.25 | 0.23 | 2.086 times |
My analysis of stock is bullish for shortterm, and stock might move up till 0.3 or till 0.3. Use a stoploss of 0.25 and if this stock hits its stoploss, then it can fall down till 0.24
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.20 |
Downside Target | 0.23 |
Downside Target | 0.24 |
Downside Target | 0.25 |
Downside Target | 0.26 |
Downside Target | 0.27 |
Upside Target | 0.29 |
Upside Target | 0.30 |
Upside Target | 0.31 |
Upside Target | 0.33 |
Upside Target | 0.56 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.24 |
Downside Intraday Target | 0.22 |
Upside Intraday Target | 0.29 |
Upside Intraday Target | 0.32 |
Downside Intraday Target | 0.27 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Thu Jul 2025 | 0.27 | 0.25 | 0.29 | 0.24 | 1.09 times |
03 Thu Jul 2025 | 0.25 | 0.24 | 0.25 | 0.23 | 0.495 times |
27 Fri Jun 2025 | 0.25 | 0.25 | 0.26 | 0.23 | 2.393 times |
20 Fri Jun 2025 | 0.25 | 0.27 | 0.27 | 0.25 | 0.392 times |
13 Fri Jun 2025 | 0.24 | 0.30 | 0.30 | 0.24 | 1.506 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Thu Jul 2025 | 0.27 | 0.24 | 0.29 | 0.23 | 0.267 times |
30 Mon Jun 2025 | 0.24 | 0.30 | 0.31 | 0.23 | 0.392 times |
30 Fri May 2025 | 0.29 | 0.27 | 0.33 | 0.25 | 0.969 times |
30 Wed Apr 2025 | 0.28 | 0.20 | 0.33 | 0.20 | 0.788 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.25 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.25 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.